A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma

References

• DeSantis CE, Siegel RL, Sauer AG, et al. Cancer Statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities. CA: a cancer journal for clinicians; 2016.
   Google Scholar
• Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921.
   PubMed Web of Science ®Google Scholar
• Mayer JE, Swetter SM, Fu T, et al. Screening, early detection, education, and trends for melanoma: current status (2007–2013) and future directions: Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology. J Am Acad Dermatol. 2014;71:599.e1–599.e12.
   PubMed Web of Science ®Google Scholar
• Choi M, Kadara H, Zhang J, et al. Mutation and immune profiles in early-stage lung squamous cell carcinoma. San Diego (CA): AACR; 2016.
   Google Scholar
• Travis WD, Rekhtman N, Riley GJ, et al. Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. J Thorac Oncol. 2010;5:411–414.
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244–285.
   PubMed Web of Science ®Google Scholar
• Schwartz AM, Rezaei MK. Diagnostic surgical pathology in lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. CHEST J. 2013;143(5_suppl):e251S–e262S.
   Web of Science ®Google Scholar
• OHara AJ, Keshavan R, Che Z, et al. An integrated comparative analysis of TCGA lung adenocarcioma and lung squamous cell carcinoma copy number and RNA-Seq expression data. San Diego (CA): AACR; 2015.
   Google Scholar
• Terry J, Leung S, Laskin J, et al. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am J Surg Pathol. 2010;34:1805–1811.
   PubMed Web of Science ®Google Scholar
• Tateishi M, Ishida T, Mitsudomi T, et al. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer Clin Oncol. 1991;27:1372–1375.
   Google Scholar
• Network CGAR. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489:519–525.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–159.
   PubMed Web of Science ®Google Scholar
• Morris KV, Mattick JS. The rise of regulatory RNA. Nat Rev Genet. 2014;15:423–437.
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–641.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Shi X, Xie Y, et al. Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA. Brief Bioinform. 2015;16(2):291.
   PubMed Web of Science ®Google Scholar
• O’Quigley J, Moreau T. Cox’s regression model: computing a goodness of fit statistic. Comput Methods Programs Biomed. 1986;22:253–256.
   PubMed Web of Science ®Google Scholar
• Wang JY, Tai J. Robust quantitative trait association tests in the parent‐offspring triad design: conditional likelihood‐based approaches. Ann Hum Genet. 2009;73:231–244.
   PubMed Web of Science ®Google Scholar
• Renaud G, Stenzel U, Maricic T, et al. deML: robust demultiplexing of Illumina sequences using a likelihood-based approach. Bioinformatics. 2015;31:770–772.
   PubMed Web of Science ®Google Scholar
• Kendall WL, Pollock KH, Brownie C. A likelihood-based approach to capture-recapture estimation of demographic parameters under the robust design. Biometrics. 1995;293–308.
   PubMed Web of Science ®Google Scholar
• Dennis G, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;51(1):293–308.
   Google Scholar
• Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337–344.
   PubMed Web of Science ®Google Scholar
• Spruance SL, Reid JE, Grace M, et al. Hazard ratio in clinical trials. Antimicrob Agents Chemother. 2004;48:2787–2792.
   PubMed Web of Science ®Google Scholar
• Cox DR. Regression models and life-tables. In: Kotz S, Johnson NL, editors. Breakthroughs in statistics. vol. 34. New York (NY): Springer; 1992. p. 527–541.
   Google Scholar
• Beland MD, Wasser EJ, Mayo-Smith WW, et al. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology. 2009;254:301–307.
   Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA: Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Chen M, Zhao H, Lind SB, et al. Data on the expression of cellular lncRNAs in human adenovirus infected cells. Data Brief. 2016;8:1263–1279.
   PubMed Web of Science ®Google Scholar
• Berrondo C, Flax J, Kucherov V, et al. Expression of the long non-coding RNA HOTAIR correlates with disease progression in bladder cancer and is contained in bladder cancer patient urinary exosomes. PLoS One. 2016;11:e0147236.
   PubMed Web of Science ®Google Scholar
• Iden M, Fye S, Huang Y, et al. HPV integration and methylation patterns in cervical intraepithelial neoplasia and invasive cervical cancer via HPV capture and high-throughput sequencing. Annual Meeting of the American Association for Cancer Research. San Diego (CA): AACR; 2014.
   Google Scholar
• Besse B, Adjei A, Baas P, et al. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease. Ann Oncol. 2014;25:1475–1484.
   PubMed Web of Science ®Google Scholar
• Reck M, Popat S, Reinmuth N, et al. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;23:56–64.
   Web of Science ®Google Scholar
• Li J, Chen Z, Tian L, et al. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut. 2014;63(11):1700.
   PubMed Web of Science ®Google Scholar
• Chen FJ, Sun M, Li SQ, et al. Upregulation of the long non‐coding rna hotair promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog. 2013;52:908–915.
   PubMed Web of Science ®Google Scholar
• Jia LF, Wei SB, Gan YH, et al. Expression, regulation and roles of miR‐26a and MEG3 in tongue squamous cell carcinoma. Int J Cancer. 2014;135:2282–2293.
   PubMed Web of Science ®Google Scholar
• Tang H, Wu Z, Zhang J, et al. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep. 2013;7:761–766.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition (1997). Cancer. 1997;80:1803–1804.
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–1474.
   PubMed Web of Science ®Google Scholar
• Lababede O, Meziane MA, Rice TW. TNM staging of lung cancer: a quick reference chart. Chest. 1999;115:233–235.
   PubMed Web of Science ®Google Scholar
• Ménoret M. The genesis of the notion of stages in oncology: the French permanent cancer survey (1943–1952). Soc Hist Med. 2002;15:291–302.
   PubMed Web of Science ®Google Scholar